Literature DB >> 7872850

Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey.

L A Warner1, R C Kessler, M Hughes, J C Anthony, C B Nelson.   

Abstract

OBJECTIVES: To analyze nationally representative data on the lifetime and 12-month prevalences of use of and dependence on illegal drugs (marijuana/hashish, cocaine/crack, heroin, hallucinogens), nonmedical prescription psychotropic drugs (sedatives, tranquilizers, stimulants, analgesics), and inhalants; and to examine data on the sociodemographic correlates of use and dependence.
METHODS: The data come from the National Comorbidity Survey, a structured diagnostic interview administered to persons aged 15 to 54 years that generates reliable diagnoses according to the definitions and criteria of DSM-III-R.
RESULTS: Of the respondents, 51.0% used one of the above drugs at some time in their lives, and 15.4% did so in the past 12 months. These estimates are similar to those obtained in the 1991 National Household Survey of Drug Abuse, where lifetime prevalence was 45.2% and 12-month prevalence was 16.7% among respondents in the age range 15 to 54 years. Of National Comorbidity Survey respondents, 7.5% (14.7% of lifetime users) were dependent at some time in their lives and 1.8% were dependent in the past 12 months. The prevalence estimate for lifetime dependence was reduced to 5.3% when calculated the percentage of respondents in the age range of 28 to 54 years who reported an onset of dependence as of 10 years earlier (ie, when they were 18 to 44 years old) was computed. This is similar to the Epidemiologic Catchment Area Study estimate of 5.1% among respondents in the age range 18 to 44 years, a comparison that matches the two studies on year of assessment, age of risk, and cohort. Males were significantly more likely to report both lifetime and 12-month use and dependence. Use and dependence were found to be more common in cohorts born after World War II than those born before the end of the war. The demographic predictors of lifetime use differed from the predictors of lifetime dependence among users, and these, in turn, differed from the predictors of recent dependence among people with a lifetime history of dependence.
CONCLUSIONS: Drug use and dependence are highly prevalent in the general population. The fact that there are differences in the correlates of first use, dependence among users, and persistence of dependence means that future research aimed at pinpointing modifiable risk factors must be based on disaggregated analyses of separate stages of progression.

Entities:  

Mesh:

Year:  1995        PMID: 7872850     DOI: 10.1001/archpsyc.1995.03950150051010

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  103 in total

1.  Contextual factors in substance use: a study of suburban and inner-city adolescents.

Authors:  S S Luthar; K D'Avanzo
Journal:  Dev Psychopathol       Date:  1999

2.  HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996.

Authors:  J E Anderson; J W Carey; S Taveras
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

3.  The visibility of illicit drugs: implications for community-based drug control strategies.

Authors:  L Saxe; C Kadushin; A Beveridge; D Livert; E Tighe; D Rindskopf; J Ford; A Brodsky
Journal:  Am J Public Health       Date:  2001-12       Impact factor: 9.308

4.  Early and mid-adolescence risk factors for later substance abuse by African Americans and European Americans.

Authors:  Andres G Gil; William A Vega; R Jay Turner
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

5.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.

Authors:  Kevin W Chen; Annie N Banducci; Leila Guller; Richard J Macatee; Anna Lavelle; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

6.  Substance use, dependence, and service utilization among the US uninsured nonelderly population.

Authors:  Li-Tzy Wu; Anthony C Kouzis; William E Schlenger
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

Review 7.  Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.

Authors:  R Andrew Chambers; Jane R Taylor; Marc N Potenza
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

8.  Birth-cohort trends in lifetime and past-year prescription opioid-use disorder resulting from nonmedical use: results from two national surveys.

Authors:  Silvia S Martins; Katherine M Keyes; Carla L Storr; Hong Zhu; Richard A Grucza
Journal:  J Stud Alcohol Drugs       Date:  2010-07       Impact factor: 2.582

9.  Clinical implications of drug abuse epidemiology.

Authors:  Jeffrey D Schulden; Marsha F Lopez; Wilson M Compton
Journal:  Psychiatr Clin North Am       Date:  2012-06

Review 10.  Genetic and environmental influences on psychiatric comorbidity: a systematic review.

Authors:  M Cerdá; A Sagdeo; J Johnson; S Galea
Journal:  J Affect Disord       Date:  2009-12-11       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.